GSK PLC GSK shares inched up 0.59% to £13.58 Tuesday, on what proved to be an all-around dismal trading session for the stock ...

GSK announced on Tuesday that its investigational antibody-drug conjugate GSK'227 has been granted breakthrough therapy ...

We recently compiled a list of the 10 Best FTSE Dividend Stocks To Buy Now. In this article, we are going to take a look at ...

GSK plc (GSK, GSK.L) said that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation for GSK5764227, its ...

In a report released today, Florent Cespedes from Bernstein maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price ...

The China National Medical Products Administration (NMPA) has approved GSK’s Nucala (mepolizumab) as an add-on treatment with ...

London open The FTSE 100 is expected to open 44 points lower on Tuesday, having closed up 0.31% on Monday at 8,249.66.

GSK took center stage last month, forming standout partnerships and alliances across multiple therapeutic areas.

On Friday, the China National Medical Products Administration approved GSK plc (NYSE:GSK) Nucala (mepolizumab) as an add-on ...

(Alliance News) - GSK PLC on Tuesday said the US Food & Drug Administration has granted a breakthrough therapy designation to its treatment for a form of bone cancer.

GSK plc (LON:GSK – Get Free Report) insider Jonathan Symonds bought 1,500 shares of the stock in a transaction on Friday, ...

GSK PLC GSK shares inched up 0.71% to £13.50 Monday, on what proved to be an all-around positive trading session for the ...